Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Quince Therapeutics Inc QNCX

Healthcare Biotechnology
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by... see more

Current News (NDAQ:QNCX)

Quince Therapeutics Announces Last Patient Last Visit in Phase 3 NEAT Clinical Trial in Patients with Ataxia-Telangiectasia

Business Wire December 15, 2025

Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders

Business Wire December 10, 2025

Quince Therapeutics to Participate at Investor Events in December 2025

Business Wire November 24, 2025

Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

Business Wire November 12, 2025

Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia

Business Wire November 10, 2025

Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting

Business Wire October 9, 2025

Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study

Business Wire September 25, 2025

Quince Therapeutics to Host Virtual Investor Day on October 2, 2025

Business Wire September 11, 2025

Quince Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Business Wire September 2, 2025
View More News ››

Opinion & Analysis (NDAQ:QNCX)

Cortexyme Secures $125M Private Placement Capital to Advance Clinical Development

Streetwise Reports February 7, 2020
View More Opinion ››

Bullboard Posts (NDAQ:QNCX)

Tomorrow there will be news

All good in the hood 
gonefishing2022 - January 7, 2026

Thank you very much to the weak hands for your cheap actions

Now we will all sell your shares cheap at $1.10 or 0.75¢ very quickly following the next very good news to come thank you.
Traderstock101 - April 25, 2025

This place used to be cool

Now posts are always like three years old lol
Buzzworth - March 21, 2023

QNCX .... Woodshed a$$ whoopin

Lol $1.04 low of day !
Iseneschal - January 27, 2023

QNCX.... I'd say this is heading straight to the "Woodshed"

Happy Fryday Cheers !
Iseneschal - January 27, 2023

QNCX ...Vols are decreasing

Big coin toss  No position !!!
Iseneschal - January 27, 2023
View more Bullboard ››

Mink Ventures Corp.

Mink Ventures Corp.

Mink Ventures Corporation engages in the acquisition, exploration, and development of mineral property interests in Canada ...
View More »

Podcasts